Please sign in to follow a disease.
Lymphoblastic lymphoma
MONDO:0000873A lymphoma composed of immature small to medium-sized precursor lymphoid cells (lymphoblasts). It includes the B- and T-cell lymphoblastic lymphoma.
Also known as: lymphoblastic lymphoma, lymphoma, lymphoblastic, malignant, precursor cell lymphoblastic lymphoma, precursor lymphoblastic lymphoma, lymphoma, lymphoblastic
2016 clinical trials for this condition and its sub-types, 78 tagged with Lymphoblastic lymphoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Lymphoblastic lymphoma
-
T-lymphoblastic lymphoma 32 trials
-
Can a smart drug missile tame Hard-to-Treat leukemia?
Disease control CompletedThis trial is investigating whether a targeted drug called CMC-544 (inotuzumab ozogamicin), given alone or later combined with rituximab, can control acute lymphoblastic leukemia (ALL) that has returned or not responded to standard treatment. The study enrolls adults and older ch…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
One cord blood unit may replace two in stem cell transplants for blood cancer
Disease control CompletedThis study tested a new way to treat blood cancers like leukemia in 16 adults who did not have a standard bone marrow donor. Doctors used a single unit of cord blood that was grown in a lab to increase the number of stem cells before transplant. The goal was to see if this method…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Selective immune cell removal may tame transplant complications
Disease control CompletedThis study tested whether removing a specific type of immune cell (naïve T cells) from donor stem cell grafts could prevent graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. The trial enrolled 84 patients who received high- or medium-intensity chemo…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Massive trial seeks best chemo cocktail for kids with leukemia
Disease control CompletedThis large phase 3 trial enrolled over 9,000 children with newly diagnosed standard-risk B-ALL or localized B-LLy. Researchers tested different combinations and doses of chemotherapy drugs to see which worked best with the fewest side effects. The goal was to improve disease-free…
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Can kids with cancer stop antibiotics sooner? new trial investigates
Disease control CompletedThis study looked at whether children with cancer and a fever caused by low white blood cells can safely stop antibiotics earlier than usual. 55 children took part, and half stopped antibiotics once their fever was gone for 48 hours, while the other half continued until their whi…
Phase 4 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Experimental CAR-T therapy targets tough blood cancers in tiny early trial
Disease control CompletedThis early-phase study tested a new cell therapy called RD13-02 in just 2 people with relapsed or refractory CD7-positive blood cancers (like T-cell leukemia or lymphoma). The treatment uses specially engineered immune cells to attack cancer cells. The main goals were to check sa…
Early phase 1 • Sponsor: MEI HENG • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Tailored combo therapy boosts leukemia fight in adults
Disease control CompletedThis study tested a personalized, intensive treatment plan for adults aged 18-55 with newly diagnosed acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. The approach used strong chemotherapy, targeted drugs like nelarabine for T-cell ALL, and risk-based stem cell trans…
Phase 3 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Experimental liposomal chemo shows promise in kids with relapsed leukemia
Disease control CompletedThis pilot study tested a liposomal form of the chemotherapy drug vincristine (Marqibo) combined with standard UK ALL R3 chemotherapy in 29 children, adolescents, and young adults with relapsed acute lymphoblastic leukemia. The main goal was to see if it was safe and tolerable at…
Phase 1 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Donor CAR-T cells take on aggressive t-cell leukemia in early trial
Disease control CompletedThis early-phase study tested a new treatment called WU-CART-007 for people with T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma that came back or didn't respond to standard therapy. The treatment uses immune cells from a healthy donor that are specially designed to…
Phase 1 • Sponsor: Wugen, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a fitness tracker and coaching get teens with leukemia moving?
Symptom relief CompletedThis study tested whether a mobile health program—including a Fitbit with movement reminders, coaching sessions, and a WhatsApp peer support group—could help 20 adolescents and young adults with acute lymphoblastic leukemia (ALL) reduce the time they spend sitting or lying down d…
Sponsor: Children's Hospital Los Angeles • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC